<DOC>
	<DOCNO>NCT00962598</DOCNO>
	<brief_summary>The purpose study examine effect 10-week Omega-3 Fatty Acid treatment phase brain chemistry adolescent major depressive disorder ( MDD ) use proton magnetic resonance imaging .</brief_summary>
	<brief_title>The Role Of Omega-3 Fatty Acids In Adolescent Depression</brief_title>
	<detailed_description>This study rest confluence finding show : 1 ) Major depressive disorder ( MDD ) , major public health concern often emerge adolescence ; entail 2 ) pathophysiological abnormality fronto-striatal structure result death atrophy glia neuron ; 3 ) omega-3 fatty acid ( FA ) effect brain function adolescent MDD assess proton magnetic resonance spectroscopy ( 1H MRS ) ; , 4 ) critical commonly use complementary alternative medicine omega-3FA face validity test neurobiological effect MDD . Using 1H MRSI , study examines effect Omega-3FA striatal anterior cingulate cortex ( ACC ) concentration neurocellular biomarkers total choline ( tCho ) , total creatine ( tCr ) , Î³-aminobutyric acid ( GABA , ACC ) adolescent MDD . Hypotheses : 1 ) relative placebo , omega-3FA treatment result significant reduction striatal ACC tCho tCr concentration , increase ACC GABA ; 2 : Regardless treatment condition ( placebo Omega-3FA ) , MDD adolescents improved end 10-week treatment exhibit significant decrease striatal ACC tCho tCr concentration , increase ACC GABA relative unimproved adolescent .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>12 19 year old ( inclusive ) sex ethnic/racial group . DSMIVTR criterion MDD MDD Duration least 8 week severity score least 40 CDRSR . Age first onset MDD least 12 year . No significant medical neurological disorder For female subject , negative pregnancy test time enrollment . Female subject sexually active use method birth control exclude . Use hormonal contraceptive ( prescribe `` birth control pill '' prescribe birth control implant ) exclusionary . Subjects must able swallow capsule . A minimum IQ 80 require . Current Past DSMIVTR diagnose bipolar disorder , schizophrenia , psychosis , autism/pervasive developmental disorder ( PDD ) , Tourette 's disorder ( TD ) . Current diagnosis eat disorder , panic disorder , obsessivecompulsive disorder ( OCD ) , post traumatic stress disorder ( PTSD ) , conduct disorder , substance related disorder nicotine . Current suicidal ideation intent plan , may pose danger . Current antidepressant treatment exclude . Past antidepressant treatment exclusionary , long patient antidepressant medication 60 day prior study entry . No individual advise terminate ongoing treatment . Certain short halflife medication , vitamin contain unidentified ingredient , St. Johns Wort , Sadenosyl Methionine ( SAM ) , clonidine , overthecounter medication . A minimum 90 day treatment long half life medication , neuroleptic , prior study entry require . Stimulant medication treatment ADHD exclusionary . If adolescent psychotherapy prior entry study , allow continue treatment . However , psychotherapy initiated time study entry .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Adolescents</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Proton Magnetic Resonance Spectroscopy</keyword>
	<keyword>Immune System Activation</keyword>
	<keyword>Omega-3 Fatty Acids</keyword>
</DOC>